Xiaobo He

2.4k total citations · 1 hit paper
69 papers, 1.8k citations indexed

About

Xiaobo He is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Xiaobo He has authored 69 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Oncology and 22 papers in Surgery. Recurrent topics in Xiaobo He's work include RNA modifications and cancer (10 papers), Bone Metabolism and Diseases (9 papers) and Renal cell carcinoma treatment (8 papers). Xiaobo He is often cited by papers focused on RNA modifications and cancer (10 papers), Bone Metabolism and Diseases (9 papers) and Renal cell carcinoma treatment (8 papers). Xiaobo He collaborates with scholars based in China, United States and Japan. Xiaobo He's co-authors include Shaodong Hong, Yan Huang, Jianhua Zhan, Wenfeng Fang, Yaxiong Zhang, Nan Chen, Tao Qin, Shiyang Kang, Ting Zhou and Yanna Tang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaobo He

64 papers receiving 1.8k citations

Hit Papers

Upregulation of PD-L1 by EGFR Activation Mediates the Imm... 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobo He China 21 943 575 546 313 293 69 1.8k
Yousef Zakharia United States 27 1.0k 1.1× 547 1.0× 732 1.3× 296 0.9× 320 1.1× 171 2.3k
Ala Abudayyeh United States 22 750 0.8× 286 0.5× 553 1.0× 197 0.6× 201 0.7× 80 1.7k
Shaoyu Yan United States 25 595 0.6× 421 0.7× 910 1.7× 326 1.0× 180 0.6× 39 1.9k
Tonya C. Walser United States 23 840 0.9× 407 0.7× 846 1.5× 423 1.4× 189 0.6× 41 2.1k
Hannes Neuwirt Austria 23 548 0.6× 483 0.8× 787 1.4× 418 1.3× 148 0.5× 62 1.8k
Katsunobu Oyama Japan 27 650 0.7× 669 1.2× 649 1.2× 283 0.9× 627 2.1× 122 2.1k
Wolfram C. M. Dempke Germany 20 727 0.8× 397 0.7× 727 1.3× 258 0.8× 119 0.4× 48 1.8k
Tsung‐Ying Yang Taiwan 27 828 0.9× 814 1.4× 682 1.2× 285 0.9× 142 0.5× 88 1.9k
Mireille Mousseau France 16 663 0.7× 635 1.1× 651 1.2× 322 1.0× 241 0.8× 40 1.5k

Countries citing papers authored by Xiaobo He

Since Specialization
Citations

This map shows the geographic impact of Xiaobo He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo He more than expected).

Fields of papers citing papers by Xiaobo He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo He. The network helps show where Xiaobo He may publish in the future.

Co-authorship network of co-authors of Xiaobo He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo He. A scholar is included among the top collaborators of Xiaobo He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo He. Xiaobo He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xiaobo, Qiuxia Wang, Denghui Wei, et al.. (2025). Lysosomal EGFR acts as a Rheb-GEF independent of its kinase activity to activate mTORC1. Cell Research. 35(7). 497–509. 3 indexed citations
2.
Zhang, Xia, Zhenxuan Chen, Xiaobo He, et al.. (2025). SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder Cancer. Advanced Science. 12(18). e2501734–e2501734. 3 indexed citations
3.
Xu, Rongrong, et al.. (2024). Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. SHILAP Revista de lepidopterología. 5(11). e789–e789. 12 indexed citations
4.
6.
Liu, Zhenhua, Zhenyu Yang, Jibin Li, et al.. (2023). Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis. Asian Journal of Surgery. 46(9). 3607–3613.
7.
He, Xiaobo, et al.. (2021). Nerve plane: An optimal surgical plane for laparoscopic rectal cancer surgery?. Medical Hypotheses. 154. 110657–110657. 5 indexed citations
8.
Yang, Chao, et al.. (2020). miR-635 Targets KIFC1 to Inhibit the Progression of Gastric Cancer. Journal of Investigative Medicine. 68(8). 1357–1363. 13 indexed citations
9.
Yan, R.H., Jianfei Luo, Xiaobo He, & Shijun Li. (2020). Association between ABC family variants rs1800977, rs4149313, and rs1128503 and susceptibility to type 2 diabetes in a Chinese Han population. Journal of International Medical Research. 48(8). 1220740899–1220740899. 5 indexed citations
10.
Guo, Shengjie, Xiangdong Li, Kai Yao, et al.. (2019). The prognostic value of the site of invasion in T3aN0M0 clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 37(5). 301.e11–301.e17. 12 indexed citations
11.
He, Xiaobo, et al.. (2019). RNA N6-methyladenosine modification participates in miR-660/E2F3 axis-mediated inhibition of cell proliferation in gastric cancer. Pathology - Research and Practice. 215(6). 152393–152393. 21 indexed citations
12.
He, Xiaobo, et al.. (2019). miR-452 promotes the development of gastric cancer via targeting EPB41L3. Pathology - Research and Practice. 216(1). 152725–152725. 17 indexed citations
13.
Chen, Qiuhong, Xiaobo He, Kai Yao, et al.. (2018). Expression and significance of Cystatin-C in clear cell renal cell carcinoma. Biomedicine & Pharmacotherapy. 107. 1237–1245. 15 indexed citations
14.
Li, Xinhua, Jian Cui, Xiaobo He, et al.. (2017). Significance of preoperative planning software for puncture and channel establishment in percutaneous endoscopic lumbar DISCECTOMY: A study of 40 cases. International Journal of Surgery. 41. 97–103. 19 indexed citations
15.
Wang, Rui, et al.. (2017). Cpt1c regulated by AMPK promotes papillary thyroid carcinomas cells survival under metabolic stress conditions. Journal of Cancer. 8(18). 3675–3681. 32 indexed citations
16.
Wang, Peng, Qiao Shi, Teng Zuo, et al.. (2016). Expression of cluster of differentiation 74 in gallbladder carcinoma and the correlation with epithelial growth factor receptor levels. Oncology Letters. 11(3). 2061–2066. 3 indexed citations
17.
Chen, Nan, Wenfeng Fang, Jianhua Zhan, et al.. (2015). Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation. Journal of Thoracic Oncology. 10(6). 910–923. 534 indexed citations breakdown →
18.
Shi, Qiao, Kailiang Zhao, Weixing Wang, et al.. (2015). Hydrogen‐Rich Saline Attenuates Acute Renal Injury in Sodium Taurocholate‐Induced Severe Acute Pancreatitis by Inhibiting ROS and NF‐κB Pathway. Mediators of Inflammation. 2015(1). 685043–685043. 43 indexed citations
19.
Zheng, Zhihui, Yi Yang, Xinhua Lu, et al.. (2011). Mycophenolic acid induces adipocyte-like differentiation and reversal of malignancy of breast cancer cells partly through PPARγ. European Journal of Pharmacology. 658(1). 1–8. 25 indexed citations
20.
Liu, Zong‐Ying, Xiaobo He, Zhaoyong Yang, et al.. (2009). Synthesis and evaluation of 1-(benzo[b]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor. Bioorganic & Medicinal Chemistry Letters. 19(15). 4167–4170. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026